Hanisch F G, Müller S, Hassan H, Clausen H, Zachara N, Gooley A A, Paulsen H, Alving K, Peter-Katalinic J
Institute of Biochemistry, University of Cologne, Joseph-Stelzmann-Strasse 52, 50931 Cologne, Germany.
J Biol Chem. 1999 Apr 9;274(15):9946-54. doi: 10.1074/jbc.274.15.9946.
In search of possible epigenetic regulatory mechanisms ruling the initiation of O-glycosylation by polypeptide:N-acetylgalactosaminyltransferases, we studied the influences of mono- and disaccharide substituents of glycopeptide substrates on the site-specific in vitro addition of N-acetylgalactosamine (GalNAc) residues by recombinant GalNAc-Ts (rGalNAc-T1, -T2, and -T3). The substrates were 20-mers (HGV20) or 21-mers (AHG21) of the MUC1 tandem repeat peptide carrying GalNAcalpha or Galbeta1-3GalNAcalpha at different positions. The enzymatic products were analyzed by MALDI mass spectrometry and Edman degradation for the number and sites of incorporated GalNAc. Disaccharide placed on the first position of the diad Ser-16-Thr-17 prevents glycosylation of the second, whereas disaccharide on the second position of Ser-16-Thr-17 and Thr-5-Ser-6 does not prevent GalNAc addition to the first. Multiple disaccharide substituents suppress any further glycosylation at the remaining sites. Glycosylation of Ser-16 is negatively affected by glycosylation at position -6 (Thr-10) or -10 (Ser-6) and is inhibited by disaccharide at position -11 (Thr-5), suggesting the occurrence of glycosylation-induced effects on distant acceptor sites. Kinetic studies revealed the accelerated addition of GalNAc to Ser-16 adjacent to GalNAc-substituted Thr-17, demonstrating positive regulatory effects induced by glycosylation on the monosaccharide level. These antagonistic effects of mono- and disaccharides could underlie a postulated regulatory mechanism.
N-乙酰半乳糖胺基转移酶引发O-糖基化的表观遗传调控机制,我们研究了糖肽底物的单糖和双糖取代基对重组GalNAc-Ts(rGalNAc-T1、-T2和-T3)在体外位点特异性添加N-乙酰半乳糖胺(GalNAc)残基的影响。底物是MUC1串联重复肽的20聚体(HGV20)或21聚体(AHG21),在不同位置携带GalNAcα或Galβ1-3GalNAcα。通过基质辅助激光解吸电离质谱(MALDI)和埃德曼降解法分析酶促产物中掺入的GalNAc的数量和位点。位于二联体Ser-16-Thr-17第一个位置的双糖会阻止第二个位置的糖基化,而位于Ser-16-Thr-17第二个位置以及Thr-5-Ser-6第二个位置的双糖不会阻止GalNAc添加到第一个位置。多个双糖取代基会抑制其余位点的进一步糖基化。Ser-16的糖基化受到-6位(Thr-10)或-10位(Ser-6)糖基化的负面影响,并被-11位(Thr-5)的双糖抑制,这表明糖基化对远处的受体位点会产生影响。动力学研究表明,GalNAc会加速添加到与GalNAc取代的Thr-17相邻的Ser-16上, 这表明糖基化在单糖水平上会产生正向调控作用。单糖和双糖的这些拮抗作用可能构成一种假定的调控机制。